Literature DB >> 11859776

Monitoring the intracellular free Ca(2+)-calmodulin concentration with genetically-encoded fluorescent indicator proteins.

Anthony Persechini1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11859776     DOI: 10.1385/1-59259-184-1:365

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


× No keyword cloud information.
  7 in total

1.  Biphasic Ca2+-dependent switching in a calmodulin-IQ domain complex.

Authors:  D J Black; Jared Leonard; Anthony Persechini
Journal:  Biochemistry       Date:  2006-06-06       Impact factor: 3.162

2.  Endothelial regulation of calmodulin expression and eNOS-calmodulin interaction in vascular smooth muscle.

Authors:  Michael G Stencel; Mark VerMeer; Jennifer Giles; Quang-Kim Tran
Journal:  Mol Cell Biochem       Date:  2022-02-16       Impact factor: 3.396

3.  Variations at the semiconserved glycine in the IQ domain consensus sequence have a major impact on Ca2+-dependent switching in calmodulin-IQ domain complexes.

Authors:  D J Black; Anthony Persechini
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

4.  The IQ domains in neuromodulin and PEP19 represent two major functional classes.

Authors:  D J Black; David LaMartina; Anthony Persechini
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

5.  Novel regulations of the angiotensin II receptor type 1 by calmodulin.

Authors:  Kevin Ehlers; Robert Clements; Mark VerMeer; Jennifer Giles; Quang-Kim Tran
Journal:  Biochem Pharmacol       Date:  2018-03-30       Impact factor: 5.858

6.  A novel assay to assess the effects of estrogen on the cardiac calmodulin binding equilibrium.

Authors:  Kyle Kaster; John Patton; Sarah Clayton; Eric Wauson; Jennifer Giles; Quang-Kim Tran
Journal:  Life Sci       Date:  2021-12-23       Impact factor: 5.037

7.  Biosensor-based approach identifies four distinct calmodulin-binding domains in the G protein-coupled estrogen receptor 1.

Authors:  Quang-Kim Tran; Mark Vermeer
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.